GTC
CATX icon

Ghost Tree Capital’s Perspective Therapeutics CATX Stock Holding History

Ghost Tree Capital’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$10M Sell
750,000
-175,000
-19% -$2.33M 3.02% 8
2024
Q2 		$9.22M Buy
925,000
+325,000
+54% +$4.7M 2.89% 11
2024
Q1 		$7.14M Buy
600,000
+440,000
+275% +$3.75M 1.98% 15
2023
Q4 		$643K Buy
+160,000
New +$450K 0.21% 50

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $172M AUM 10.38% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Ghost Tree Capital's CATX Position: Q3 2024 in Review

Ghost Tree Capital reduced its Perspective Therapeutics (CATX) stake by 19% in Q3 2024, selling an estimated $2.33M and leaving 750,000 shares worth $10M. The position accounts for 3.02% of the portfolio, ranked #8.

Ghost Tree Capital first reported a position in CATX in Q4 2023 and has held it in 4 quarters since. 127 funds tracked by Wall St. Rank hold CATX as of Q3 2024.

  • Ghost Tree Capital held 750,000 shares of Perspective Therapeutics worth $10M as of Q3 2024.
  • Ghost Tree Capital sold 175,000 Perspective Therapeutics shares in Q3 2024, an estimated $2.33M.
  • Perspective Therapeutics made up 3.02% of Ghost Tree Capital's portfolio in Q3 2024, its #8 holding.
  • Ghost Tree Capital first reported a position in Perspective Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • 127 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q3 2024.

Based on Ghost Tree Capital's 13F filing for Q3 2024, filed 14 Nov 2024.